HER-2 POSITIVE BREAST CANCER
Clinical trials for HER-2 POSITIVE BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new HER-2 POSITIVE BREAST CANCER trials appear
Sign up with your email to follow new studies for HER-2 POSITIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise in shrinking aggressive breast cancer before surgery
Disease control OngoingThis study tests two drugs, T-DM1 and pertuzumab, given before surgery to people with early-stage HER2-positive breast cancer. The goal is to see if this combination can completely eliminate cancer cells in the breast. About 164 participants with stage II or III breast cancer are…
Matched conditions: HER-2 POSITIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 16, 2026 12:48 UTC
-
New drug cocktail shows promise for Tough-to-Treat breast cancer
Disease control OngoingThis study tests whether adding the drug palbociclib to standard hormone and anti-HER2 therapy helps people with a specific type of advanced breast cancer (HR+/HER2+) live longer without the disease getting worse. About 518 adults with metastatic breast cancer that cannot be remo…
Matched conditions: HER-2 POSITIVE BREAST CANCER
Phase: PHASE3 • Sponsor: Alliance Foundation Trials, LLC. • Aim: Disease control
Last updated Jun 15, 2026 19:05 UTC
-
New drug combo shows promise for Hard-to-Treat breast cancer
Disease control OngoingThis study tests a combination of two drugs, sacituzumab govitecan and trastuzumab, in 28 people with HER2+ breast cancer that has spread and stopped responding to a previous treatment. The goal is to see if the combination can shrink tumors or slow the disease. Participants rece…
Matched conditions: HER-2 POSITIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Adrienne G. Waks • Aim: Disease control
Last updated Jun 08, 2026 13:07 UTC